← Eichor
Study identifier: NCT06603194 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults

Condition: Skin Laxity · Hair Thinning · Nails  ·  Sponsor: Ancient + Brave

PhaseNA
Planned participants90
Who can joinFemale, 35 Years to 55 Years
Healthy volunteersYes

About this study

The BECOME Study (Bovine and Marine Collagen Efficacy for Skin, Hair, Nails and Whole Body Health Markers Evaluation) is a randomized controlled trial designed to compare the effects of bovine and marine collagen supplements versus a placebo on skin, hair, nails and whole body health markers. The trial aims to determine the most efficacious collagen source for improving health outcomes and to establish if both types of collagen are equally effective. Participants will be assessed on various health parameters, including skin elasticity, joint health, digestive health, and overall well-being, over a specified period.

This description comes directly from the study's public registry record.

Talk to the study team

Jenna Macciochi, PhD  ·  +447799090189  ·  jenna@ancientandbrave.earth

Becky Clarke  ·  beckyclarke@princetonconsumer.com

Always discuss trial participation with your own doctor first.

Locations (1)

Princeton Consumer Research, 8 Richmond Road, Dukes ParkChelmsford, Essex, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06603194